We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+10.96%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$771B
AUM Growth
+$65B
Cap. Flow
+$3.26B
Cap. Flow %
0.42%
Top 10 Hldgs %
21.76%
Holding
2,605
New
87
Increased
1,561
Reduced
802
Closed
81

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$6.97B
2
AMD icon
Advanced Micro Devices
AMD
+$1.37B
3
LULU icon
lululemon athletica
LULU
+$1.32B
4
SPOT icon
Spotify
SPOT
+$1.28B
5
NOW icon
ServiceNow
NOW
+$1.25B

Top Sells

Rank Stock Value
1
BA icon
Boeing
BA
+$3.41B
2
NOC icon
Northrop Grumman
NOC
+$2.36B
3
MSFT icon
Microsoft
MSFT
+$2.2B
4
MCD icon
McDonald's
MCD
+$1.85B
5
ICE icon
Intercontinental Exchange
ICE
+$1.28B

Sector Composition

Rank Sector Weight
1 Technology 21.34%
2 Healthcare 16.78%
3 Financials 13.77%
4 Consumer Discretionary 12.98%
5 Communication Services 10.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRTX icon
26
Vertex Pharmaceuticals
VRTX
$134B
$5.37B 0.7%
24,525,905
-1,764,208
-7% -$357M
TMO icon
27
Thermo Fisher Scientific
TMO
$224B
$5.3B 0.69%
16,301,983
-772,368
-5% -$234M
NOW icon
28
ServiceNow
NOW
$132B
$5.14B 0.67%
91,024,335
+23,758,525
+35% +$1.25B
CI icon
29
Cigna
CI
$72.4B
$5.04B 0.65%
24,646,957
+799,899
+3% +$147M
BKNG icon
30
Booking.com
BKNG
$160B
$4.7B 0.61%
57,166,850
-3,322,750
-5% -$261M
WFC icon
31
Wells Fargo
WFC
$264B
$4.59B 0.59%
85,280,386
-8,049,298
-9% -$422M
SRE icon
32
Sempra
SRE
$55.9B
$4.43B 0.57%
58,461,694
-4,052,764
-6% -$297M
PYPL icon
33
PayPal
PYPL
$50.5B
$4.08B 0.53%
37,682,006
+698,388
+2% +$72.8M
SPLK
34
DELISTED
Splunk Inc
SPLK
$3.98B 0.52%
26,563,342
-350,206
-1% -$46M
MRSH
35
Marsh
MRSH
$91.3B
$3.94B 0.51%
35,408,306
+258,248
+0.7% +$27M
DG icon
36
Dollar General
DG
$26.5B
$3.94B 0.51%
25,260,085
-557,321
-2% -$88.4M
WDAY icon
37
Workday
WDAY
$44.8B
$3.71B 0.48%
22,584,772
+117,421
+0.5% +$19.5M
CB icon
38
Chubb
CB
$134B
$3.63B 0.47%
23,341,203
+2,945,784
+14% +$451M
APTV icon
39
Aptiv
APTV
$10.3B
$3.55B 0.46%
37,407,598
-9,031,755
-19% -$827M
ASML icon
40
ASML
ASML
$691B
$3.53B 0.46%
11,939,769
+3,805,088
+47% +$1.03B
AIG icon
41
American International
AIG
$40.4B
$3.52B 0.46%
68,551,070
-7,072,350
-9% -$375M
ELV icon
42
Elevance Health
ELV
$84.7B
$3.48B 0.45%
11,516,140
-362,880
-3% -$99.9M
WTW icon
43
Willis Towers Watson
WTW
$31.8B
$3.34B 0.43%
16,516,574
+340,558
+2% +$65.3M
QCOM icon
44
Qualcomm
QCOM
$171B
$3.3B 0.43%
37,414,988
+11,266,277
+43% +$943M
DIS icon
45
Walt Disney
DIS
$179B
$3.25B 0.42%
22,504,920
+1,651,839
+8% +$231M
MS icon
46
Morgan Stanley
MS
$338B
$3.17B 0.41%
62,059,629
+21,035,558
+51% +$996M
FTV icon
47
Fortive
FTV
$18.6B
$3.16B 0.41%
65,561,930
-12,873,451
-16% -$581M
NXPI icon
48
NXP Semiconductors
NXPI
$59.6B
$3.13B 0.41%
24,601,010
+3,181,225
+15% +$369M
JNJ icon
49
Johnson & Johnson
JNJ
$626B
$3.08B 0.4%
21,147,858
+2,884,267
+16% +$391M
PPLI
50
People Inc
PPLI
$2.97B
$3.08B 0.4%
69,071,495
-3,040,942
-4% -$123M

Similar funds

T. Rowe Price Associates's Q4 2019 Portfolio in Review

As of Q4 2019, T. Rowe Price Associates held 2,605 positions worth $771B, up 9.2% from $706B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

T. Rowe Price Associates's Q4 2019 filing shows 87 new, 1,561 increased, 802 reduced and 81 closed positions. Its largest new stake was XP: 7,905,172 shares worth $305M. The largest sale was Boeing, an estimated $3.41B.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q4 2019 buy was XP: 7,905,172 shares worth $305M.
  • T. Rowe Price Associates added most to Apple in Q4 2019, an estimated $6.97B increase.
  • T. Rowe Price Associates's biggest Q4 2019 reduction was Boeing, cutting an estimated $3.41B.
  • T. Rowe Price Associates fully exited Viacom Inc. Class B in Q4 2019, selling an estimated $204M.
  • T. Rowe Price Associates's ten largest holdings make up 22% of its $771B portfolio in Q4 2019.
  • T. Rowe Price Associates opened 87 new positions and closed 81 in Q4 2019.
  • T. Rowe Price Associates's portfolio value rose 9.2% quarter-over-quarter to $771B.

Based on T. Rowe Price Associates's 13F filing for Q4 2019, filed 14 Feb 2020.